RxDoctor Payments Data

Robert Liem

Pediatric Hematology-Oncology · Chicago, ILNPI 1548238926

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $1,657 of the $1,953 with a category attached, or 84.9%. Novartis accounts for 65.4% of it on its own, with 2 other manufacturers making up the rest.

$1,953in general payments, 2019–2025

Across 9 payments — averaging $217.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$1K
  • CSL Behring$659
  • Chiesi USA, Inc.$16
$1,823,680in research payments, 2019–2025

Across 66 payments — averaging $27,632 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Vertex$1.2M
  • Genetix Biotherapeutics Inc$491K
  • Global Blood Therapeutics, Inc.$99K

What the payments were for

  • Travel & lodging$1,65785%
  • Food & beverage$28014%
  • Education$161%

General payments by program year

19
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novartis4$1,278
CSL Behring4$659
Chiesi USA, Inc.1$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,953 in reported general payments places this provider in the 65th percentile of 78 pediatric hematology-oncology providers in Illinois.

See all pediatric hematology-oncology providers in Illinois

Other pediatric hematology-oncology in Chicago

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →